Showing results (1-10 of 1,363) with videos related to
Sort By:
Pageof 137
European Journal of Pharmacology|September 5, 1995
Fenfluramine's appetite suppression and serotonin neurotoxicity are separableU D McCann, J Yuan, G A RicaurteNeuropsychobiology|June 27, 2000
(+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: studies in animalsG A Ricaurte, J Yuan, U D McCannSynapse (New York, N.Y.)|October 17, 1998
Neurotoxic effects of +/-fenfluramine and phenteramine, alone and in combination, on monoamine neurons in the mouse brainU D McCann, J Yuan, G A RicaurteThe Journal of Pharmacology and Experimental Therapeutics|June 1, 1997
Selective serotonin reuptake inhibitors dissociate fenfluramine's anorectic and neurotoxic effects: importance of dose, species and drugU D McCann, J Yuan, G Hatzidimitriou, et al.Brain Research|April 5, 1991
Major metabolites of (+/-)3,4-methylenedioxyamphetamine (MDA) do not mediate its toxic effects on brain serotonin neuronsU D McCann, G A RicaurteJournal of Clinical Psychopharmacology|October 1, 1991
Lasting neuropsychiatric sequelae of (+-)methylenedioxymethamphetamine ('ecstasy') in recreational usersU D McCann, G A RicaurteNIDA Research Monograph|January 1, 1993
Strategies for detecting subclinical monoamine depletions in humansU D McCann, G A RicaurteAnnals of the New York Academy of Sciences|May 11, 1992
Neurotoxic amphetamine analogues: effects in monkeys and implications for humansG A Ricaurte, U D McCannNeurotoxicity Research|April 28, 2004
Experimental studies on 3,4-methylenedioxymethamphetamine (MDA, "ecstasy") and its potential to damage brain serotonin neuronsG A Ricaurte, U D McCannJournal of Clinical Psychopharmacology|June 1, 1993
Reinforcing subjective effects of (+/-) 3,4-methylenedioxymethamphetamine ("ecstasy") may be separable from its neurotoxic actions: clinical evidenceU D McCann, G A RicaurtePageof 137